New research points toward better and longer lasting diabetes treatments
University of Copenhagen
446 views
The latest findings, which were published in Nature Communications, build on research by Professor Michael Schwartz from the University of Washington. Several years ago, he discovered that injecting a single dose of the protein FGF1 targets the brain and cures diabetes in mice.
Associate Professor Tune H. Pers from the Novo Nordisk Foundation Center for Basic Metabolic Research teamed up with the Schwartz Lab to better understand how FGF1 affects the brains of mice.
They were able to find
that particular neurons within the hypothalamus are changed in a sustained way
and that this change is critical to induce long lasting diabetes remission. The research could
pave the way for new diabetes treatments that are more effective and long
lasting. It also challenges the
prevailing wisdom and about the cause, and potential cure, for diabetes.
Read the full article in Nature Communications here: Transcriptomic analysis links diverse hypothalamic cell types to fibroblast growth factor 1-induced sustained diabetes remission